Disclaimer

efalizumab - subcutaneous injection, Raptiva

GENERIC NAME: EFALIZUMAB - SUBCUTANEOUS INJECTION (EF-a-LIZ-ue-mab)

BRAND NAME(S): Raptiva

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: Efalizumab decreases immune system function (immunosuppression), which can result in very serious (possibly fatal) infections (e.g., tuberculosis, meningitis, PML), or a worsening of an existing infection. Seek immediate medical attention if you develop signs of serious infection such as persistent fever/cough, difficulty breathing, confusion, loss of balance, sudden vision/speech problems.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright


STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!